---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-047156"
form_type: "8-K"
ticker: "PAVM"
cik: "0001624326"
company_name: "PAVmed Inc."
filed_at: "2024-11-21T23:59:59+00:00"
generated_at: "2026-05-29T20:47:05.441927+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# PAVmed exchanges $22.3M convertible notes for Series C Preferred Stock and enters separate $2.65M purchase

## Summary
- Exchanged $22,347,543 principal amount of Senior Secured Convertible Notes for 22,347 shares of Series C Preferred Stock.
- Series C Preferred Stock carries 7.875% annual dividend, convertible at $1.068 per share, and redeemable at 132.5% of stated value.
- Company will seek stockholder approval by Jan 31, 2025 to increase authorized common stock from 50M to 250M shares.
- Separate Securities Purchase Agreement for $2,652,456.76 of unsecured debt cancelled in exchange for 2,653 additional Series C Preferred shares.
- Outstanding convertible note balance reduced to approximately $6.4 million after exchange; remaining note maturity extended to Dec 31, 2025.

## SEC filing metadata
- accession: 0001493152-24-047156
- form_type: 8-K
- ticker: PAVM
- cik: 0001624326
- company_name: PAVmed Inc.
- filed_at: 2024-11-21T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 3.02, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1624326/000149315224047156/0001493152-24-047156-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1624326/000149315224047156/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-047156
- JSON: https://secwatch.observer/filing/0001493152-24-047156.json
- Plain text: https://secwatch.observer/filing/0001493152-24-047156.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.